Rachel Evans

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Patient Reported Outcomes

Artificial Intelligence

Top Venues

Journal of comparative effectiveness research

Targeted oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Neil Hawkins, Noemi Muszbek, Rachel Evans, Linda McNamara, Trefor Jones
Overall survival in the UK in mycosis fungoides or Sézary syndrome cutaneous T-cell lymphoma: comparative effectiveness of mogamulizumab versus current standard of care. Journal of comparative effectiveness research (2023)
Valerie Aponte Ribero, Monica Daigl, Yasmina Martí, Ksenija Gorni, Rachel Evans, David Alexander Scott, Anadi Mahajan, Keith R Abrams, Neil Hawkins
How does risdiplam compare with other treatments for Types 1-3 spinal muscular atrophy: a systematic literature review and indirect treatment comparison. Journal of comparative effectiveness research 11 (5) (2022)
Neil Hawkins, Noemi Muszbek, Rachel Evans, Pascale Dequen-O'Byrne, Trefor Jones, Linda McNamara
Adjusting for treatment crossover in the MAVORIC trial: survival in advanced mycosis fungoides and Sézary syndrome. Journal of comparative effectiveness research 11 (11) (2022)
Rachel Evans, Neil Hawkins, Pascale Dequen-O'Byrne, Charles McCrea, Dominic Muston, Christopher Gresty, Sameer R Ghate, Lin Fan, Robert Hettle, Keith R Abrams, Johann de Bono, Maha Hussain, Neeraj Agarwal
Exploring the Impact of Treatment Switching on Overall Survival from the PROfound Study in Homologous Recombination Repair (HRR)-Mutated Metastatic Castration-Resistant Prostate Cancer (mCRPC). Targeted oncology 16 (5) (2021)